The DES Center

Filter Your Results

 

News

 

Five-Year Data Presented for Biotronik's Orsiro DES

November 2, 2017 -- Biotronik announced that the company's Orsiro drug-eluting stent (DES) demonstrated high rates of long-term safety and clinical performance according t…

Synergy Stent With Shorter DAPT Compared to BMS in Elderly Patients in SENIOR Trial

November 1, 2017 -- Elderly patients undergoing PCI often receive bare-metal stents (BMSs) instead of drug-eluting stents (DESs) to shorten the duration of dual antiplatelet t…

Study Compares DAPT Durations in STEMI Patients Receiving DES

November 1, 2017 -- Results from the DAPT STEMI were reported at TCT 2017, the 29th annual Transcatheter Cardiovascular Therapeutics scientific symposium being held October 30…

REDUCE Compares 3- and 12-Month DAPT in ACS Patients Treated With the Combo DES

November 1, 2017 -- Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported at TCT 2017, the 29th annual Transcatheter Cardiova…

ABSORB IV Results Show Need for Improvements in BVS Technology and Technique

October 31, 2017 -- Thirty-day results from ABSORB IV randomized everolimus-eluting trial of the Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) found the BVS to…

Cordis Unveils Comprehensive Interventional Cardiology Portfolio With Coronary Stents

October 30, 2017­ -- Cordis, a Cardinal Health Company announced the addition of two new coronary stents to its comprehensive interventional cardiology portfolio, the Tryt…

Three-Year ABSORB III Trial Data Presented and Published for Abbott Vascular's BVS

October 31, 2017 -- The ABSORB III study assessed clinical outcomes through 3 years after implantation of the Absorb everolimus-eluting poly-L-lactic acid -- based bioresorbab…

CE Mark Approval for Abbott Vascular's Xience Sierra

October 30, 2017 -- Abbott Vascular announced it has received European CE Mark approval for Xience Sierra, the newest generation of the company’s Xience everolimus-eluti…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.